Well-established industry leader whose oncology expertise and transactions record has led to multiple approved therapeutic products and advanced clinical …
PRESS RELEASES
Meet Mark Kubik, Head of Business Development – Oncology
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Live webcast on Thursday, May 29th at 2:20 PM ET BOSTON and LONDON – May 22, 2025 – Akari Therapeutics, Plc …